In the Mediterranean region almost all patients with hepatitis B virus (HBV)-related cirrhosis are anti-HBV e antigen (anti-HBeAg)-positive and carriers of HBeAg-negative virus mutants. The six members of a family who acquired HBV infection were recently studied: two siblings developed cirrhosis with persistence of HBeAg positivity, whereas their parents and two more siblings cleared the virus. The two cirrhotic patients showed homozygosity for HLA class I by phenotype, which is a rare occurrence in the general population, while the other family members were heterozygous for HLA class I. The sequencing analyses of the entire viral DNAs isolated from both cirrhotic patients showed that the two viral genomes were almost identical and no mutation preventing HBeAg synthesis or viral gene expression was present. These findings might suggest that homozygosity for HLA class I molecules might be responsible for an insufficient response to the virus, favouring chronic outcome of the infection and the long-lasting persistence of HBV populations that produce HBeAg.
The pathogenic mechanisms responsible for viral persistence and liver damage in chronic hepatitis B virus (HBV) infection are only partially understood. Defects in the immune response and the genetics of the host probably play a central role (Chisari & Ferrari, 1995 ; Thursz et al., 1995) , but evidence also suggests that viral genetic heterogeneity may influence the outcome of the infection, either allowing escape of mutant viruses from immune surveillance (Bertoletti et aI., 1994a, b) or providing the virus with a positive growth advantage sufficient to favour its selection and persistence (Lok et al., 1994) . HBV Author for correspondence: Giovanni Raimondo. Fax +39 90 2935162 genomic variants that are unable to synthesize the HBV e antigen (HBeAg) are commonly detected (Pollicino et al., 1995) . These are usually produced by a G to A point mutation occurring at nucleotide position 1896 (numbering from the unique EcoRI restriction site in the viral genome) and transforming codon 28 (the penultimate) of the precore region into a translational stop codon (Brunetto et al., 1989; Carman et a]., 1989) . This variant, which is widespread in the Mediterranean basin and several other geographical areas, is usually detected in patients positive for antibody to HBeAg (anti-HBe), who are the great majority of chronically HBVinfected subjects in the Mediterranean area (Tur-Kaspa et al., 1984) . For instance, among the last 100 HBV surface antigen (HBsAg) carriers admitted to our Department, 84 individuals were anti-HBe-and 16 were HBeAg-positive (unpublished data). In addition, almost all HBV cirrhotic patients are antiHBe positive, and this is not surprising considering that: (i) seroconversion from HBeAg to anti-HBe is the rule in the outcome of chronic HBV infection (Realdi et al., 1980; Hoofnagle et aL, I981) ; (ii) several reports demonstrate that the emergence and selection of HBeAg-defective variants is a very frequent event in long-lasting HBV infections (Okamoto eta[., 1990; Takayanagi eta]., 1993; Hamasaki eta] ., 1994), likely because it represents an advantage for viral persistence (Brunetto et al., I991; Lok et al., 1994) ; and (iii) progression to cirrhosis usually takes many years after the development of a chronic HBV infection, which is an event often occurring in childhood (Gregorio et al., 1993) .
Recently we have observed the unusual finding of two HBsAg/HBeAg-positive patients with cirrhosis among the members of a Sicilian family and now we report the results of our analyses.
A 42-year-old woman was admitted to our Department because of a severe form of decompensated cirrhosis which led her to death in 2 weeks. She was HBsAg/HBeAg-positive. The members of her family were also tested for serum HBV markers and liver function, although none of them had been referred previously with liver disease. The parents, one brother (45 years old) and one sister (35 years old) tested positive for antibodies to HBsAg (anti-HBs) and to HBV core antigen (HBcAg/anti-HBc) and had no evidence of liver disease, showing normal liver biochemistry and sonography; on the contrary one brother was HBsAg/HBeAg-positive and showed aminotransferase levels raised fourfold compared to normal values. This brother (38 years old) agreed to undergo needle liver biopsy and histological examination showed a pattern of severe chronic active hepatitis with cirrhosis. HBcAg reactivity was tested, by immunohistochemical method, on 5 Ixm sections of the liver specimen: a focal pattern with both nuclear and cytoplasmic staining was detected. The two cirrhotic patients had no history of alcohol or drug abuse and were negative for antibodies to hepatitis C virus and Delta viruses (HCV, HDV: Anti-HCV EIA 2nd generation, Anti-Delta EIA; Abbott and RIBA 3.0; Chiron) and for autoantibodies to mitochondria, nucleus, smooth muscle and microsomes. The absence of HCV or HDV infection was confirmed by lack of detection of the specific viral RNAs in the sera tested by nested PCR.
In an attempt to obtain information about the possible mechanism(s) responsible for the different behaviour of HBV infection in the two siblings who developed cirrhosis (characterized by the long-lasting persistence of HBeAg positivity) compared to their relatives who succeeded in clearing the virus, we analysed: (i) the class I and II human HLA phenotype in all members of the family, because of the critical role played by HLA molecules in the presentation of viral peptides to T cells; (ii) the nucleotide sequences of the entire HBV genomes isolated from both cirrhotic patients, to determine whether they were infected by an identical HBV variant carrying peculiar genomic rearrangement(s).
HLA class I and class II typing was performed by a standard microlymphocytotoxicity technique. Serum HBV DNA from the two cirrhotic siblings was first detected by dot-blot hybridization technique (Lieberman et al., 1983) which showed low viraemia levels (5 pg/100 p,l) in both cases. This result was subsequently confirmed using the Abbott HBV DNA kit. HBV DNA was extracted from lml of serum from the two chronically infected siblings, following a previously described method (Raimondo et al., 1990a, b) . Using several pairs of synthetic oligonucleotide primers the entire viral genomes were amplified and the products of amplifications were directly sequenced in both directions, according to previously reported procedures (Raimondo et al., 1990 a, b) . The sequences obtained were compared with those of the National Center for Biotechnology Information data bank. PCR amplification was also performed on DNA extracted from serum samples of the four anti-HBs-positive members of the family, but viral sequences were not found in any of them.
The results of our analyses showed that the two cirrhotic siblings expressed the same HLA class I phenotype (Ad-B35-Cw4), which was different from those observed in the other family members (Table I) . Homozygosity for A, B and C HLA class I alleles is an infrequent finding in the general population, and it has been observed only in I2 out of 2000 healthy subjects consecutively tested in our area as potential donors for bone marrow transplantation. More specifically, the Ad-B35-Cw4 pattern has been detected only in three individuals. Consequently, it has to be considered a rare event to observe patients with HBV infection and HLA class I homozygosity. Except for the cirrhotic sister, the members of the family were also tested for HLA class II, and all of them, including the cirrhotic brother, showed phenotypes commonly observed in the general population (Table i) .
The sequencing analysis of the HBV DNA isolated from the two patients demonstrated that the two viral genomes were almost identical, showing 99% nucleotide sequence identity, thus strongly suggesting the intrafamilial spread of the same viral strain. Moreover, we may assume that the very few differences in HBV sequences between brother and sister had no relevance in the pathogenesis of their disease considering that both of them showed the same clinical evolution. Comparing the two viral sequences with those of the known HBV isolates, they matched best with the ayw subtype described by Galibert et al. (1979) , which is the most frequently detected subtype in the Mediterranean area. A limited number of point mutations producing amino acid changes in the viral proteins were found in both the cases (26 in the sister and 24 in the brother), as shown in Table 2 , and none were able to prevent HBeAg synthesis. Moreover, some of the above-mentioned amino acid changes (I2 in the sister and 10 in the brother) had already been observed in other HBV isolates (Table 2) .
Summarizing, our data show that all members of the family acquired HBV infection, but, while four of them cleared the virus, two siblings became chronic carriers and developed a severe and evolving form of liver disease. In consideration of the epidemiological data about HBV cirrhosis in our area, the lack of emergence of HBeAg-defective virus in the two patients was really surprising, as well as their low levels of HBV viraemia and the focal nuclear/cytoplasmic pattern of HBcAg reactivity observed in the liver specimen examined, which are reported to be typical features of anti-HBe-positive chronic active hepatitis (Bonino et al., i986). Pre-core Core
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TTT ( This peculiar behaviour was associated with a limited number of point mutations of the infecting virus, as shown by the high similarity of its sequence with that of the most commonly detected HBV subtype in our area. Even in the absence of gross genomic rearrangements or large numbers of point mutations, however, we cannot completely rule out the possibility that a few of the existing mutations may have affected immunodominant T cell epitopes critical for protection, or that new immunogenic sequences may have been created by single amino acid substitutions. Unfortunately, the techniques available to study the HLA class I-and class IIrestricted T cell responses to HBV do not allow us to address these issues directly.
Finally, we can only speculate about the possible implications, with respect to the outcome of infection, of homozygosity at the level of the HLA class I molecules which is a quite unusual finding. It is well known that HLA molecules play an essential role in the process of recognition of the infecting virus by T cells since they are responsible for the presentation of the antigenic peptides, derived from the processing of the different viral proteins, to the T cell receptor. Since each HLA molecule is presumably able to present a different set of peptides to T cells, homozygosity, at least in theory, should mean a more limited capacity of cytotoxic T cells to counteract viral insult as a result of a more restricted repertoire of specificities and a lower vigour of response. This may be particularly relevant if the infecting virus contains a limited number of amino acid sequences able to bind with sufficient affinity to the HLA class I molecules expressed by the homozygous infected patient and this factor could impose a serious constraint on the host's cytotoxic T lymphocyte (CTL) repertoire. In this scenario, the potential weakness of the CTL response may be responsible for a less efficiently controlled viral replication and a higher likelihood of viral persistence (Bertoletti e~ at., 1994b) . In any case, additional studies are needed to define the real influence that HLA haplotypes can exert on the final outcome of infection by the above or other undefined mechanisms.
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